[HTML][HTML] Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City
The clinical impact of coronavirus disease 2019 in primary immunodeficiency diseases
varies from mild illness to death. In our center, humoral immunodeficiency patients with poor …
varies from mild illness to death. In our center, humoral immunodeficiency patients with poor …
SARS-CoV-2 antibodies in breast milk after vaccination
DS Romero Ramírez, MM Lara Pérez… - …, 2021 - publications.aap.org
METHODS We conducted a prospective cohort single-institution study from February 2 to
April 4, 2021. Women who reported to be breastfeeding at the time of their coronavirus …
April 4, 2021. Women who reported to be breastfeeding at the time of their coronavirus …
Immune profile and clinical outcome of breakthrough cases after vaccination with an inactivated SARS-CoV-2 vaccine
Constant efforts to prevent infections by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are actively carried out around the world. Several vaccines are currently …
(SARS-CoV-2) are actively carried out around the world. Several vaccines are currently …
Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021
T Shimabukuro - American Journal of Transplantation, 2021 - amjtransplant.org
1| DISCUSSION Early safety monitoring of Moderna COVID-19 vaccine detected 10 cases of
anaphylaxis after reported administration of 4041396 first doses of Moderna COVID-19 …
anaphylaxis after reported administration of 4041396 first doses of Moderna COVID-19 …